Share Price and Basic Stock Data
Last Updated: April 3, 2025, 8:01 pm
PEG Ratio | 0.25 |
---|
Competitors of Morganite Crucible (India) Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Morganite Crucible (India) Ltd | 788 Cr. | 1,406 | 1,964/1,170 | 28.8 | 246 | 2.84 % | 28.3 % | 20.2 % | 5.00 |
Associated Ceramics Ltd | 67.0 Cr. | 223 | 634/190 | 46.9 | 75.6 | 0.00 % | 5.69 % | 4.09 % | 10.0 |
Vesuvius India Ltd | 9,185 Cr. | 4,516 | 6,000/3,238 | 34.7 | 705 | 0.32 % | 26.4 % | 20.2 % | 10.0 |
IFGL Refractories Ltd | 1,341 Cr. | 373 | 755/326 | 28.5 | 306 | 1.87 % | 8.97 % | 7.82 % | 10.0 |
Industry Average | 3,771.33 Cr | 1,629.50 | 34.73 | 333.15 | 1.26% | 17.34% | 13.08% | 8.75 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 41.36 | 40.63 | 40.27 | 38.85 | 41.49 | 33.98 | 42.69 | 45.35 | 40.00 | 39.90 | 42.90 | 44.31 | 44.66 |
Expenses | 31.50 | 35.88 | 33.75 | 31.94 | 33.43 | 30.23 | 31.19 | 32.51 | 31.50 | 34.28 | 32.12 | 31.48 | 34.18 |
Operating Profit | 9.86 | 4.75 | 6.52 | 6.91 | 8.06 | 3.75 | 11.50 | 12.84 | 8.50 | 5.62 | 10.78 | 12.83 | 10.48 |
OPM % | 23.84% | 11.69% | 16.19% | 17.79% | 19.43% | 11.04% | 26.94% | 28.31% | 21.25% | 14.09% | 25.13% | 28.96% | 23.47% |
Other Income | 16.25 | 11.32 | 1.15 | 0.23 | 1.82 | 1.64 | 1.15 | 1.12 | 2.83 | -2.20 | 1.96 | 1.75 | 2.75 |
Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.04 | 0.06 | 0.03 | 0.08 | 0.08 | 0.05 |
Depreciation | 2.09 | 1.84 | 1.77 | 1.94 | 2.02 | 2.03 | 2.04 | 2.21 | 2.11 | 2.09 | 1.95 | 2.17 | 2.31 |
Profit before tax | 24.02 | 14.23 | 5.90 | 5.20 | 7.86 | 3.36 | 10.61 | 11.71 | 9.16 | 1.30 | 10.71 | 12.33 | 10.87 |
Tax % | 24.40% | 6.96% | 26.61% | 25.00% | 24.94% | 40.77% | 26.48% | 29.04% | 27.07% | 46.92% | 26.33% | 27.74% | 27.78% |
Net Profit | 18.17 | 13.24 | 4.33 | 3.91 | 5.90 | 1.99 | 7.80 | 8.31 | 6.67 | 0.70 | 7.90 | 8.92 | 7.85 |
EPS in Rs | 32.45 | 23.64 | 7.73 | 6.98 | 10.54 | 3.55 | 13.93 | 14.84 | 11.91 | 1.25 | 14.11 | 15.93 | 14.02 |
Last Updated: March 6, 2025, 4:56 pm
Below is a detailed analysis of the quarterly data for Morganite Crucible (India) Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹44.66 Cr.. The value appears strong and on an upward trend. It has increased from 44.31 Cr. (Sep 2024) to ₹44.66 Cr., marking an increase of 0.35 Cr..
- For Expenses, as of Dec 2024, the value is ₹34.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.48 Cr. (Sep 2024) to ₹34.18 Cr., marking an increase of 2.70 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹10.48 Cr.. The value appears to be declining and may need further review. It has decreased from 12.83 Cr. (Sep 2024) to ₹10.48 Cr., marking a decrease of 2.35 Cr..
- For OPM %, as of Dec 2024, the value is 23.47%. The value appears to be declining and may need further review. It has decreased from 28.96% (Sep 2024) to 23.47%, marking a decrease of 5.49%.
- For Other Income, as of Dec 2024, the value is ₹2.75 Cr.. The value appears strong and on an upward trend. It has increased from 1.75 Cr. (Sep 2024) to ₹2.75 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Dec 2024, the value is ₹0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.08 Cr. (Sep 2024) to ₹0.05 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Dec 2024, the value is ₹2.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.17 Cr. (Sep 2024) to ₹2.31 Cr., marking an increase of 0.14 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹10.87 Cr.. The value appears to be declining and may need further review. It has decreased from 12.33 Cr. (Sep 2024) to ₹10.87 Cr., marking a decrease of 1.46 Cr..
- For Tax %, as of Dec 2024, the value is 27.78%. The value appears to be increasing, which may not be favorable. It has increased from 27.74% (Sep 2024) to 27.78%, marking an increase of 0.04%.
- For Net Profit, as of Dec 2024, the value is ₹7.85 Cr.. The value appears to be declining and may need further review. It has decreased from 8.92 Cr. (Sep 2024) to ₹7.85 Cr., marking a decrease of 1.07 Cr..
- For EPS in Rs, as of Dec 2024, the value is 14.02. The value appears to be declining and may need further review. It has decreased from 15.93 (Sep 2024) to 14.02, marking a decrease of 1.91.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 5, 2025, 5:21 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 80 | 81 | 89 | 89 | 111 | 109 | 120 | 129 | 107 | 152 | 155 | 168 | 172 |
Expenses | 62 | 64 | 70 | 68 | 83 | 86 | 100 | 111 | 96 | 122 | 129 | 129 | 132 |
Operating Profit | 18 | 17 | 18 | 20 | 29 | 23 | 20 | 17 | 10 | 30 | 25 | 39 | 40 |
OPM % | 22% | 21% | 21% | 23% | 26% | 21% | 17% | 13% | 10% | 20% | 16% | 23% | 23% |
Other Income | 1 | 2 | 0 | 2 | 2 | 3 | 6 | 7 | 1 | 32 | 5 | 3 | 4 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 4 | 5 | 8 | 7 | 5 | 4 | 4 | 5 | 6 | 7 | 8 | 8 | 9 |
Profit before tax | 14 | 13 | 11 | 16 | 26 | 21 | 22 | 18 | 6 | 54 | 22 | 33 | 35 |
Tax % | 40% | 37% | 44% | 36% | 37% | 35% | 30% | 29% | 116% | 20% | 28% | 28% | |
Net Profit | 9 | 8 | 6 | 10 | 17 | 14 | 15 | 13 | -1 | 43 | 16 | 23 | 25 |
EPS in Rs | 15.27 | 15.04 | 10.75 | 17.64 | 29.64 | 24.79 | 27.45 | 23.43 | -1.66 | 77.48 | 28.79 | 41.95 | 45.31 |
Dividend Payout % | 3% | 3% | 5% | 11% | 13% | 32% | 29% | 34% | 0% | 70% | 69% | 95% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -11.11% | -25.00% | 66.67% | 70.00% | -17.65% | 7.14% | -13.33% | -107.69% | 4400.00% | -62.79% | 43.75% |
Change in YoY Net Profit Growth (%) | 0.00% | -13.89% | 91.67% | 3.33% | -87.65% | 24.79% | -20.48% | -94.36% | 4507.69% | -4462.79% | 106.54% |
Morganite Crucible (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 7% |
3 Years: | 16% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 11% |
3 Years: | 151% |
TTM: | 11% |
Stock Price CAGR | |
---|---|
10 Years: | 17% |
5 Years: | 15% |
3 Years: | 9% |
1 Year: | -4% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 15% |
3 Years: | 21% |
Last Year: | 20% |
Last Updated: Unknown
Balance Sheet
Last Updated: March 14, 2025, 1:28 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Reserves | 45 | 53 | 58 | 67 | 77 | 88 | 96 | 105 | 100 | 120 | 124 | 126 | 135 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Other Liabilities | 28 | 27 | 14 | 18 | 38 | 23 | 28 | 32 | 37 | 32 | 34 | 45 | 43 |
Total Liabilities | 76 | 82 | 75 | 88 | 118 | 114 | 127 | 139 | 139 | 155 | 161 | 174 | 182 |
Fixed Assets | 25 | 23 | 18 | 15 | 25 | 27 | 31 | 32 | 30 | 38 | 53 | 62 | 65 |
CWIP | 0 | 0 | 1 | 3 | 2 | 0 | 4 | 19 | 22 | 15 | 1 | 0 | 2 |
Investments | 5 | 5 | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Assets | 46 | 54 | 51 | 65 | 91 | 87 | 93 | 88 | 87 | 102 | 106 | 112 | 115 |
Total Assets | 76 | 82 | 75 | 88 | 118 | 114 | 127 | 139 | 139 | 155 | 161 | 174 | 182 |
Below is a detailed analysis of the balance sheet data for Morganite Crucible (India) Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹135.00 Cr.. The value appears strong and on an upward trend. It has increased from 126.00 Cr. (Mar 2024) to ₹135.00 Cr., marking an increase of 9.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹1.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹43.00 Cr.. The value appears to be improving (decreasing). It has decreased from 45.00 Cr. (Mar 2024) to ₹43.00 Cr., marking a decrease of 2.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹182.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 174.00 Cr. (Mar 2024) to ₹182.00 Cr., marking an increase of 8.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹65.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Mar 2024) to ₹65.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to ₹2.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹115.00 Cr.. The value appears strong and on an upward trend. It has increased from 112.00 Cr. (Mar 2024) to ₹115.00 Cr., marking an increase of 3.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹182.00 Cr.. The value appears strong and on an upward trend. It has increased from 174.00 Cr. (Mar 2024) to ₹182.00 Cr., marking an increase of 8.00 Cr..
Notably, the Reserves (₹135.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 18.00 | 17.00 | 18.00 | 20.00 | 29.00 | 23.00 | 20.00 | 17.00 | 10.00 | 30.00 | 25.00 | 38.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 64 | 61 | 50 | 59 | 60 | 57 | 52 | 66 | 76 | 75 | 64 | 58 |
Inventory Days | 150 | 156 | 142 | 149 | 158 | 179 | 159 | 158 | 143 | 136 | 124 | 116 |
Days Payable | 249 | 232 | 116 | 119 | 129 | 176 | 161 | 145 | 178 | 154 | 146 | 185 |
Cash Conversion Cycle | -35 | -15 | 75 | 89 | 89 | 60 | 49 | 78 | 41 | 57 | 42 | -11 |
Working Capital Days | 23 | 41 | 69 | 67 | 5 | 60 | 44 | 62 | 33 | 71 | 48 | 17 |
ROCE % | 31% | 27% | 19% | 24% | 36% | 25% | 23% | 18% | 8% | 39% | 18% | 28% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
Diluted EPS (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
Cash EPS (Rs.) | 75.38 | 66.81 | 52.61 | 51.15 | 55.75 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 343.51 | 285.76 | 253.44 | 234.62 | 204.61 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 343.51 | 285.76 | 253.44 | 234.62 | 204.61 |
Revenue From Operations / Share (Rs.) | 397.75 | 392.35 | 393.06 | 360.68 | 357.27 |
PBDIT / Share (Rs.) | 109.55 | 95.26 | 71.70 | 72.15 | 81.96 |
PBIT / Share (Rs.) | 91.91 | 65.59 | 39.72 | 52.18 | 65.20 |
PBT / Share (Rs.) | 91.91 | 65.59 | 39.70 | 50.95 | 65.06 |
Net Profit / Share (Rs.) | 57.74 | 37.14 | 20.62 | 31.18 | 38.99 |
NP After MI And SOA / Share (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
PBDIT Margin (%) | 27.54 | 24.28 | 18.24 | 20.00 | 22.94 |
PBIT Margin (%) | 23.10 | 16.71 | 10.10 | 14.46 | 18.25 |
PBT Margin (%) | 23.10 | 16.71 | 10.09 | 14.12 | 18.20 |
Net Profit Margin (%) | 14.51 | 9.46 | 5.24 | 8.64 | 10.91 |
NP After MI And SOA Margin (%) | 13.04 | 9.09 | 5.23 | 8.36 | 9.62 |
Return on Networth / Equity (%) | 16.56 | 13.64 | 8.92 | 14.24 | 18.81 |
Return on Capital Employeed (%) | 26.60 | 22.62 | 15.54 | 21.43 | 30.91 |
Return On Assets (%) | 12.30 | 9.59 | 6.28 | 8.50 | 10.51 |
Asset Turnover Ratio (%) | 1.00 | 0.98 | 1.02 | 0.92 | 1.00 |
Current Ratio (X) | 4.01 | 3.14 | 2.71 | 1.92 | 1.67 |
Quick Ratio (X) | 3.27 | 2.41 | 1.87 | 1.33 | 1.11 |
Inventory Turnover Ratio (X) | 2.26 | 2.14 | 2.25 | 2.07 | 2.12 |
Dividend Payout Ratio (NP) (%) | 0.00 | 11.21 | 4.86 | 3.31 | 2.90 |
Dividend Payout Ratio (CP) (%) | 0.00 | 6.12 | 1.90 | 1.99 | 1.95 |
Earning Retention Ratio (%) | 0.00 | 88.79 | 95.14 | 96.69 | 97.10 |
Cash Earning Retention Ratio (%) | 0.00 | 93.88 | 98.10 | 98.01 | 98.05 |
Interest Coverage Ratio (X) | 0.00 | 0.00 | 2707.05 | 58.75 | 569.16 |
Interest Coverage Ratio (Post Tax) (X) | 0.00 | 0.00 | 779.53 | 26.39 | 271.76 |
Enterprise Value (Cr.) | 210.89 | 92.31 | 144.85 | 65.34 | 77.58 |
EV / Net Operating Revenue (X) | 1.89 | 0.84 | 1.32 | 0.64 | 0.77 |
EV / EBITDA (X) | 6.87 | 3.46 | 7.21 | 3.23 | 3.38 |
MarketCap / Net Operating Revenue (X) | 2.23 | 1.04 | 1.39 | 0.75 | 0.85 |
Retention Ratios (%) | 0.00 | 88.78 | 95.13 | 96.68 | 97.09 |
Price / BV (X) | 2.83 | 1.56 | 2.38 | 1.29 | 1.68 |
Price / Net Operating Revenue (X) | 2.23 | 1.04 | 1.39 | 0.75 | 0.85 |
EarningsYield | 0.05 | 0.08 | 0.03 | 0.11 | 0.11 |
After reviewing the key financial ratios for Morganite Crucible (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For Diluted EPS (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For Cash EPS (Rs.), as of Mar 17, the value is 75.38. This value is within the healthy range. It has increased from 66.81 (Mar 16) to 75.38, marking an increase of 8.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 343.51. It has increased from 285.76 (Mar 16) to 343.51, marking an increase of 57.75.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 343.51. It has increased from 285.76 (Mar 16) to 343.51, marking an increase of 57.75.
- For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 397.75. It has increased from 392.35 (Mar 16) to 397.75, marking an increase of 5.40.
- For PBDIT / Share (Rs.), as of Mar 17, the value is 109.55. This value is within the healthy range. It has increased from 95.26 (Mar 16) to 109.55, marking an increase of 14.29.
- For PBIT / Share (Rs.), as of Mar 17, the value is 91.91. This value is within the healthy range. It has increased from 65.59 (Mar 16) to 91.91, marking an increase of 26.32.
- For PBT / Share (Rs.), as of Mar 17, the value is 91.91. This value is within the healthy range. It has increased from 65.59 (Mar 16) to 91.91, marking an increase of 26.32.
- For Net Profit / Share (Rs.), as of Mar 17, the value is 57.74. This value is within the healthy range. It has increased from 37.14 (Mar 16) to 57.74, marking an increase of 20.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For PBDIT Margin (%), as of Mar 17, the value is 27.54. This value is within the healthy range. It has increased from 24.28 (Mar 16) to 27.54, marking an increase of 3.26.
- For PBIT Margin (%), as of Mar 17, the value is 23.10. This value exceeds the healthy maximum of 20. It has increased from 16.71 (Mar 16) to 23.10, marking an increase of 6.39.
- For PBT Margin (%), as of Mar 17, the value is 23.10. This value is within the healthy range. It has increased from 16.71 (Mar 16) to 23.10, marking an increase of 6.39.
- For Net Profit Margin (%), as of Mar 17, the value is 14.51. This value exceeds the healthy maximum of 10. It has increased from 9.46 (Mar 16) to 14.51, marking an increase of 5.05.
- For NP After MI And SOA Margin (%), as of Mar 17, the value is 13.04. This value is within the healthy range. It has increased from 9.09 (Mar 16) to 13.04, marking an increase of 3.95.
- For Return on Networth / Equity (%), as of Mar 17, the value is 16.56. This value is within the healthy range. It has increased from 13.64 (Mar 16) to 16.56, marking an increase of 2.92.
- For Return on Capital Employeed (%), as of Mar 17, the value is 26.60. This value is within the healthy range. It has increased from 22.62 (Mar 16) to 26.60, marking an increase of 3.98.
- For Return On Assets (%), as of Mar 17, the value is 12.30. This value is within the healthy range. It has increased from 9.59 (Mar 16) to 12.30, marking an increase of 2.71.
- For Asset Turnover Ratio (%), as of Mar 17, the value is 1.00. It has increased from 0.98 (Mar 16) to 1.00, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 17, the value is 4.01. This value exceeds the healthy maximum of 3. It has increased from 3.14 (Mar 16) to 4.01, marking an increase of 0.87.
- For Quick Ratio (X), as of Mar 17, the value is 3.27. This value exceeds the healthy maximum of 2. It has increased from 2.41 (Mar 16) to 3.27, marking an increase of 0.86.
- For Inventory Turnover Ratio (X), as of Mar 17, the value is 2.26. This value is below the healthy minimum of 4. It has increased from 2.14 (Mar 16) to 2.26, marking an increase of 0.12.
- For Dividend Payout Ratio (NP) (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.21 (Mar 16) to 0.00, marking a decrease of 11.21.
- For Dividend Payout Ratio (CP) (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.12 (Mar 16) to 0.00, marking a decrease of 6.12.
- For Earning Retention Ratio (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.79 (Mar 16) to 0.00, marking a decrease of 88.79.
- For Cash Earning Retention Ratio (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.88 (Mar 16) to 0.00, marking a decrease of 93.88.
- For Interest Coverage Ratio (X), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 16) which recorded 0.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 16) which recorded 0.00.
- For Enterprise Value (Cr.), as of Mar 17, the value is 210.89. It has increased from 92.31 (Mar 16) to 210.89, marking an increase of 118.58.
- For EV / Net Operating Revenue (X), as of Mar 17, the value is 1.89. This value is within the healthy range. It has increased from 0.84 (Mar 16) to 1.89, marking an increase of 1.05.
- For EV / EBITDA (X), as of Mar 17, the value is 6.87. This value is within the healthy range. It has increased from 3.46 (Mar 16) to 6.87, marking an increase of 3.41.
- For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 2.23. This value is within the healthy range. It has increased from 1.04 (Mar 16) to 2.23, marking an increase of 1.19.
- For Retention Ratios (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 88.78 (Mar 16) to 0.00, marking a decrease of 88.78.
- For Price / BV (X), as of Mar 17, the value is 2.83. This value is within the healthy range. It has increased from 1.56 (Mar 16) to 2.83, marking an increase of 1.27.
- For Price / Net Operating Revenue (X), as of Mar 17, the value is 2.23. This value is within the healthy range. It has increased from 1.04 (Mar 16) to 2.23, marking an increase of 1.19.
- For EarningsYield, as of Mar 17, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 16) to 0.05, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morganite Crucible (India) Ltd:
- Net Profit Margin: 14.51%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 26.6% (Industry Average ROCE: 17.34%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.56% (Industry Average ROE: 13.08%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.8 (Industry average Stock P/E: 34.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.51%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Refractories | B-11, MIDC Waluj, Aurangabad Maharashtra 431136 | Sales.India@morganplc.com http://www.morganmms.com |
Management | |
---|---|
Name | Position Held |
Mr. Mukund Bhogale | Chairman & Ind.Director |
Mr. Aniruddha Karve | Director |
Mr. Jonathan Percival | Director |
Ms. Maithilee Tambolkar | Independent Director |
Mr. Ulhas Gaoli | Independent Director |
FAQ
What is the intrinsic value of Morganite Crucible (India) Ltd?
Morganite Crucible (India) Ltd's intrinsic value (as of 03 April 2025) is ₹1177.42 — 16.26% lower the current market price of ₹1,406.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 788 Cr. market cap, FY2025-2026 high/low of ₹1,964/1,170, reserves of 135 Cr, and liabilities of 182 Cr.
What is the Market Cap of Morganite Crucible (India) Ltd?
The Market Cap of Morganite Crucible (India) Ltd is 788 Cr..
What is the current Stock Price of Morganite Crucible (India) Ltd as on 03 April 2025?
The current stock price of Morganite Crucible (India) Ltd as on 03 April 2025 is 1,406.
What is the High / Low of Morganite Crucible (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morganite Crucible (India) Ltd stocks is ₹1,964/1,170.
What is the Stock P/E of Morganite Crucible (India) Ltd?
The Stock P/E of Morganite Crucible (India) Ltd is 28.8.
What is the Book Value of Morganite Crucible (India) Ltd?
The Book Value of Morganite Crucible (India) Ltd is 246.
What is the Dividend Yield of Morganite Crucible (India) Ltd?
The Dividend Yield of Morganite Crucible (India) Ltd is 2.84 %.
What is the ROCE of Morganite Crucible (India) Ltd?
The ROCE of Morganite Crucible (India) Ltd is 28.3 %.
What is the ROE of Morganite Crucible (India) Ltd?
The ROE of Morganite Crucible (India) Ltd is 20.2 %.
What is the Face Value of Morganite Crucible (India) Ltd?
The Face Value of Morganite Crucible (India) Ltd is 5.00.